Description
ABP 501, D2E7, Adalimumab, Adalimumab Beta, CAS: 331731-18-1
Targets
TNF, Tumor necrosis factor ligand superfamily member 2, N-terminal fragment, ICD2, NTF, TNF-a, TNF-alpha, Tumor necrosis factor, TNFSF2, TNFA, Cachectin, ICD1
Isotypes/Mimetics
IgG1, kappa
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Naive display libraries derived from human B cells
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression